Search | IOVS | ARVO Journals

Showing 1 – 20 of 26

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

3-hydroxykynurenin concentration changes in retina after partial optic nerve crush and NMDA-induced RGC damage in rat

Tomasz Choragiewicz; Sebastian Thaler; Frank Schuettauf; Kamila Wertejuk; Dominika Nowakowska; Michael J Koss; Tomasz Kocki; Anselm G M Junemann; Waldemar A Turski; Robert Rejdak

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):388. doi:

ARVO Annual Meeting Abstract April 2010

Tempol Protects Against Indocyanine Green Induced Retinal Changes in vivo

M. Fiedorowicz; A. Schatz; G. Willmann; B. Voykov; T. J. Choragiewicz; C. A. May; F. Schuettauf; T. Zarnowski; R. Rejdak; S. Thaler

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3586. doi:

ARVO Annual Meeting Abstract April 2010

Neuroprotective Effect of Ketone Bodies and Ketogenic Diet in Nmda-Induced Rgc Damage in Rat. Possible Involvement of Kynurenic Acid?

T. J. Choragiewicz; S. Thaler; R. Rejdak; M. Fiedorowoicz; W. A. Turski; T. Kocki; M. Tulidowicz-Bielak; E. Zrenner; F. Schuettauf; T. Zarnowski

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3715. doi:

Retinal Cell Biology January 2009

Efficacy of Rho-kinase Inhibition in Promoting Cell Survival and Reducing Reactive Gliosis in the Rodent Retina

PDF

Aysegül Tura; Frank Schuettauf; Philippe P. Monnier; Karl U. Bartz-Schmidt; Sigrid Henke-Fahle
TAGS: cell survival, gliosis, phosphotransferases, retina, neuroglia, cytokine, rodentia, culture media, conditioned, mice
Invest. Ophthalmol. Vis. Sci.. 2009; 50(1):452-461. doi: https://doi.org/10.1167/iovs.08-1973

ARVO Annual Meeting Abstract May 2008

Age-Dependent Neuroprotection of Retinal Ganglion Cells by Tempol C8-acyl Ester in a Rat NMDA Toxicity Model

M. Fiedorowicz; S. Thaler; R. Rejdak; F. Schuettauf; E. Zrenner; M. Wozniak; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):868. doi:

ARVO Annual Meeting Abstract May 2008

In vivo Toxicity Testing of Intravitreal Bevacizumab (Avastin) and Ranibizumab (Lucentis) in Rat Models With and Without Retinal Ganglion Cell Damage

S. Thaler; F. Ziemssen; M. Fiedorowicz; T. Choragiewicz; S. Bolz; E. Zrenner; K.-U. Bartz-Schmidt; F. Schuettauf

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4579. doi:

ARVO Annual Meeting Abstract May 2008

Neuroprotective Effect of the Ketone Bodies Acetoacetate and β-hydroxybutyrate on Retinal Ganglion Cells in a Rat Model of NMDA Toxicity

T. J. Choragiewicz; S. Thaler; F. Schuettauf; R. Rejdak; E. Zrenner; T. Zarnowski

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5502. doi:

Retina May 2008

In Vivo Toxicity Study of Rhodamine 6G in the Rat Retina

PDF

Sebastian Thaler; Christos Haritoglou; Tomasz J. Choragiewicz; Andre Messias; Aneta Baryluk; C. Albrecht May; Robert Rejdak; Michal Fiedorowicz; Eberhart Zrenner; Frank Schuettauf
TAGS: electroretinography, eye, retina, toxic effect, dyes, recovery of function, injection site, injections
Invest. Ophthalmol. Vis. Sci.. 2008; 49(5):2120-2126. doi: https://doi.org/10.1167/iovs.07-1476

ARVO Annual Meeting Abstract May 2007

Caspase Inhibitors Are Protective in NMDA-Mediated Retinal Ganglion Cell Death

F. Schuettauf; T. Stein; T. Choragiewicz; R. Rejdak; S. Bolz; D. Zurakowski; M. A. Varde; A. M. Laties; S. Thaler

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):641. doi:

ARVO Annual Meeting Abstract May 2007

A Murine Opa1 Mutant Features Pathology of Autosomal Dominant Optic Atrophy

M. Alavi; S. Bette; S. Schimpf; F. Schuettauf; U. Schraermeyer; N. Tanimoto; H. F. Wehrl; M. Knipper; J. Laufs; B. Wissinger

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2463. doi:

ARVO Annual Meeting Abstract May 2007

Neuroprotective Effects of Tempol and Its Acyl Esters in a Rat Partial Optic Nerve Crush Model

S. Thaler; F. Schuettauf; R. Rejdak; T. J. Choragiewicz; T. Zarnowski; E. Zrenner; Z. Wypych; N. Knap; M. Wozniak; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3286. doi:

ARVO Annual Meeting Abstract May 2007

Toxicity Study of Rhodamine in the Rat Retina

T. J. Choragiewicz; S. Thaler; F. Schuettauf; A. Messias; A. Baryluk; C. A. May; R. Rejdak; Z. Zagorski; E. Zrenner; C. Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3682. doi:

Glaucoma September 2006

Novel Mutations of FOXC1 and PITX2 in Patients with Axenfeld-Rieger Malformations

PDF

Nicole Weisschuh; Paul Dressler; Frank Schuettauf; Christiane Wolf; Bernd Wissinger; Eugen Gramer
TAGS: congenital abnormality, mutation, genes, nucleotides
Invest. Ophthalmol. Vis. Sci.. 2006; 47(9):3846-3852. doi: https://doi.org/10.1167/iovs.06-0343

Retina August 2006

Administration of Novel Dyes for Intraocular Surgery: An In Vivo Toxicity Animal Study

PDF

Frank Schuettauf; Christos Haritoglou; Christian A. May; Robert Rejdak; Anna Mankowska; Wolfgang Freyer; Kirsten Eibl; Eberhart Zrenner; Anselm Kampik; Sebastian Thaler
TAGS: dyes, toxic effect, ophthalmologic surgical procedures, animal testing, eye
Invest. Ophthalmol. Vis. Sci.. 2006; 47(8):3573-3578. doi: https://doi.org/10.1167/iovs.06-0211

ARVO Annual Meeting Abstract May 2006

Novel Dyes for Intraocular Surgery: First in–vivo Toxicity Testing Results

F. Schuettauf; R. Rejdak; C.A. May; S. Thaler; W. Freyer; C. Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3231. doi:

ARVO Annual Meeting Abstract May 2005

Tempol Protects RGC Against Partial Optic Verve Crush With and Without Iron Load in the Rat

F. Schuettauf; R.A. Rejdak; S. Thaler; K. Dietrich; Z. Zagorski; E. Zrenner; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1263. doi:

ARVO Annual Meeting Abstract May 2005

Downregulation of KAT II in Retinal Ganglion Cells via Intravitreal or Retrograde Delivery of Antisense Oligonucleotides

S. Thaler; R. Rejdak; K. Dietrich; S. Bolz; W.A. Turski; Z. Zagorski; E. Zrenner; F. Schuettauf

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1317. doi:

ARVO Annual Meeting Abstract May 2005

P2X7–Receptor Expression Is Upregulated During Degenerative Ganglion Cell Loss in Retinas of DBA/2J–Mice

J.E. Fries; F. Schuettauf; E. Zrenner; K.L. Kohler

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4010. doi:

ARVO Annual Meeting Abstract May 2005

Expression of L–Kynurenine Aminotransfrases in Corpora Amylacea in the Human Retina and Optic Nerve

R.A. Rejdak; C. Rummelt; F. Schuettauf; E. Zrenner; Z. Zagorski; T. Zarnowski; U. Schlötzer–Schrehardt; G.O. H. Naumann; F. Kruse; A.G. M. Junemann

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4241. doi:

ARVO Annual Meeting Abstract May 2004

Citicoline and/or lithium rescue retinal ganglion cells following callibrated partial optic nerve crush in the rat

R.A. Rejdak; F. Schuettauf; C. Lehaci; S. Thaler; S. Bolz; T. Zarnowski; Z. Zagorski; P. Grieb; E. Zrenner

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):827. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

3-hydroxykynurenin concentration changes in retina after partial optic nerve crush and NMDA-induced RGC damage in rat

Tempol Protects Against Indocyanine Green Induced Retinal Changes in vivo

Neuroprotective Effect of Ketone Bodies and Ketogenic Diet in Nmda-Induced Rgc Damage in Rat. Possible Involvement of Kynurenic Acid?

Efficacy of Rho-kinase Inhibition in Promoting Cell Survival and Reducing Reactive Gliosis in the Rodent Retina

Age-Dependent Neuroprotection of Retinal Ganglion Cells by Tempol C8-acyl Ester in a Rat NMDA Toxicity Model

In vivo Toxicity Testing of Intravitreal Bevacizumab (Avastin) and Ranibizumab (Lucentis) in Rat Models With and Without Retinal Ganglion Cell Damage

Neuroprotective Effect of the Ketone Bodies Acetoacetate and β-hydroxybutyrate on Retinal Ganglion Cells in a Rat Model of NMDA Toxicity

In Vivo Toxicity Study of Rhodamine 6G in the Rat Retina

Caspase Inhibitors Are Protective in NMDA-Mediated Retinal Ganglion Cell Death

A Murine Opa1 Mutant Features Pathology of Autosomal Dominant Optic Atrophy

Neuroprotective Effects of Tempol and Its Acyl Esters in a Rat Partial Optic Nerve Crush Model

Toxicity Study of Rhodamine in the Rat Retina

Novel Mutations of FOXC1 and PITX2 in Patients with Axenfeld-Rieger Malformations

Administration of Novel Dyes for Intraocular Surgery: An In Vivo Toxicity Animal Study

Novel Dyes for Intraocular Surgery: First in–vivo Toxicity Testing Results

Tempol Protects RGC Against Partial Optic Verve Crush With and Without Iron Load in the Rat

Downregulation of KAT II in Retinal Ganglion Cells via Intravitreal or Retrograde Delivery of Antisense Oligonucleotides

P2X7–Receptor Expression Is Upregulated During Degenerative Ganglion Cell Loss in Retinas of DBA/2J–Mice

Expression of L–Kynurenine Aminotransfrases in Corpora Amylacea in the Human Retina and Optic Nerve

Citicoline and/or lithium rescue retinal ganglion cells following callibrated partial optic nerve crush in the rat

To View More...

You must be signed into an individual account to use this feature.